MANNATECH INC

MTEX · XNAS

CIK 1056358fmd_0DZ4HFKT3H2PVQA7K5KZVTSR6SManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Jan 01, 2007 to Sep 30, 2026, 75 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	180	177	174	158	151	160	137	132	118	108
Cost of revenue	37	36	34	32	36	34	33	29	26	27
Net interest income	0	0	0	(0)	0	0	0	0	(0)	–
Gross profit	144	141	139	126	116	126	104	103	91	81
Research and development	1	1	1	1	1	1	1	1	1	1
Selling, general and administrative	–	–	–	–	–	–	–	75	42	40
Total operating expenses	143	139	139	120	111	117	105	104	90	81
Operating income	1	3	(0)	6	4	9	(0)	(1)	1	(0)
Interest expense	–	–	–	–	–	–	–	0	0	0
Interest and investment income	–	–	–	–	–	–	–	–	–	–
Other non-operating income (expense)	(2)	(0)	0	(1)	1	(0)	(0)	(0)	3	(2)
Income before taxes	(1)	2	0	6	6	9	(0)	(1)	4	(3)
Income tax expense	(0)	4	4	2	(1)	(1)	4	1	1	12
Net income from continuing operations	(1)	(2)	(4)	3	6	10	(4)	(2)	2	(15)
Net income	(1)	(2)	(4)	3	6	10	(4)	(2)	2	(15)